Abstract Δ9-THC/CBD reduced TMD pain from 7.35 to 3.50 on the VAS scale. Functional gain: mouth opening increased from 45.9…
Abstract Background: Cannabidiol (CBD) has demonstrated potential as a therapeutic agent for muscle tension, pain, and sleep bruxism, yet its…
Abstract Background: Cannabidiol (CBD), a non-intoxicating phytocannabinoid, has garnered interest as a potential therapeutic agent for managing pain and inflammation…
Abstract Background: Temporomandibular disorders (TMDs) are a group of conditions affecting the temporomandibular joint (TMJ) and associated muscles, leading to…
Abstract The management of orofacial pain to alleviate the quality of life of affected patients is becoming increasingly challenging for…